Proactive therapy of atopic eczema - An evidence-based concept with a behavioral background;Proaktive therapie des atopischen ekzems - Ein evidenzbasiertes therapiekonzept mit verhaltenstherapeutischem hintergrund

JDDG - Journal of the German Society of Dermatology

Volumn 7, Issue 2, 2009, Pages 117-121

  Wollenberg, Andreas ^a   Frank, Reiner ^a   Kroth, Julia ^a   Ruzicka, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atopic eczema; Fluticasone; Proactive therapy; Tacrolimus ointment

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; FLUTICASONE PROPIONATE; PIMECROLIMUS; PLACEBO; STEROID; TACROLIMUS;

ATOPIC DERMATITIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DERMATITIS; DISEASE COURSE; DISEASE SEVERITY; ECZEMA; EVIDENCE BASED PRACTICE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; PERSONAL EXPERIENCE; QUALITY OF LIFE; REVIEW; SKIN INFILTRATE; SKIN INFLAMMATION; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS AS TOPIC; DERMATITIS, ATOPIC; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 59249100223     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2008.06772.x     Document Type: Review

References (34)

1. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003 361 : 151 160.
2. Ring J, Przybilla B, Ruzicka T (eds.). Handbook of Atopic Eczema, 2nd Edition, Springer, Berlin, 2005.
3. Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006 154 : 719 725.
4. Darsow U, Lübbe J, Taieb A, Seidenari S, Wollenberg A, Calza A, Giusti F, Ring J. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005 19 : 286 295.
5. Wollenberg A. Proaktive und reaktive Behandlungsansätze der Neurodermitis mit differenten Externa. J Dtsch Dermatol Ges 2007 5, Suppl 2 : S105.
6. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006 43 : 159 169.
7. Ogawa H, Yoshiike T. Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment. Pediatr Dermatol 1992 9 : 383 385.
8. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985 65 : 102 105.
9. Holm EA, Wulf HC, Thomassen L, Jemec GB. Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema. J Am Acad Dermatol 2006 55 : 772 780.
10. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007 120 : 150 155.
11. Kerschenlohr K, Darsow U, Burgdorf WHC, Ring J, Wollenberg A. Lessons of Atopy Patch Testing in Atopic Dermatitis. Curr Allergy Asthma Rep 2004 4 : 285 289.
12. Darsow U, Laifaoui J, Kerschenlohr K, Wollenberg A, Przybilla B, Wüthrich B, Borelli Sj, F. Giusti F, Seidenari S, Drzimalla K, Simon D, Disch R, Borelli S, Devillers ACA, Oranje AP, De Raeve L, Hachem JP, Dangoisse C, Blondeel A, Song M, Breuer K, Wulf A, Werfel T, Roul S, Taieb A, Bolhaar S, Bruijnzeel-Koomen C, Brönnimann M, Braathen LR, Didierlaurent A, André C, Ring J. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004 59 : 1318 1325.
13. Habig J, Vocks E, Kautzky F, Ring J. Biophysical characteristics of healthy skin and nonlesional skin in atopic dermatitis: short-term effects of ultraviolet A and B irradiation. Skin Pharmacol Appl Skin Physiol 2000 13 : 174 181.
14. Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002 119 : 166 173.
15. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O' Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, Di Giovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006 38 : 441 446.
16. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, Klopp N, Wagenpfeil S, Zhao Y, Liao H, Lee SP, Palmer CN, Jenneck C, Maintz L, Hagemann T, Behrendt H, Ring J, Nothen MM, McLean WH, Novak N. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006 118 : 214 219.
17. Braun-Falco O, Plewig G, Wolff H, Burgdorf W. Dermatology. 3rd edition, Springer, New York, Heidelberg, Berlin, 2000.
18. Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976 67 : 305 312.
19. Bieber T, Braun-Falco O. IgE-bearing Langerhans cells are not specific to atopic eczema but are found in inflammatory skin diseases. J Am Acad Dermatol 1991 24 : 658 659.
20. Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, de la Salle C. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 1992 175 : 1285 1290.
21. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Födinger D, Kinet J, Stingl G. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 1992 175 : 1353 1365.
22. Wollenberg A, Wen S, Bieber T. Phenotyping of epidermal dendritic cells - clinical applications of a flow cytometric micromethod. Cytometry 1999 37 : 147 155.
23. Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002 147 : 528 537.
24. Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003 326 : 1367 1372.
25. Bornhövd E, Burgdorf WHC, Wollenberg A. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. J Am Acad Dermatol 2001 45 : 736 743.
26. Bieber T, Cork M, Ellis C, Girolomoni G, Groves R, Langley R, Luger T, Meurer M, Murrell D, Orlow S, Paller A, de Prost Y, Puig L, Ring J, Saurat JH, Schwarz T, Shear N, Stingl G, Taieb A, Thestrup-Pedersen K. Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology 2005 211 : 77 78.
27. Luger TA, Bieber T, Meurer M, Mrowietz U, Schwarz T, Simon J, Werfel T, Zuberbier T. Therapie des atopischen Ekzems mit Calcineurin-Inhibitoren. J Dtsch Dermatol Ges 2005 3 : 385 391.
28. Wollenberg A, Reitamo S, Girolomoni G, Lahfa M, Ruzicka T, Healy E, Gianetti A, Bieber T, Finlay AY, Deleuran M. A novel approach to disease control with 0.1% Tacrolimus ointment in adults with atopic dermatitis: results of a randomized, multicentre, comparative study. Allergy 2008 63 : 742 750.
29. Wollenberg A, Sidhu MK, Odeyemi I, Dorsch B, Koehne-Volland, R, Schaff M, Ehlken B, Berger K. Economic evaluation of secondary prophylactic treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol In press L. Verhaltensmedizinische Programme bei Hautpatienten. In : Petermann F, Warschburger P : Neurodermitis. Göttingen : Hogrefe, 1999 : 209 228.
30. Scholz OB. Das atopische Ekzem aus verhaltensmedizinischer Sicht. In : Petermann F, Warschburger P. Neuro-dermitis. Göttingen : Hogrefe, 1999 : 113 140.
31. Warschburger P. Verhaltenstherapie bei Neurodermitis. Mschr Khk 2005 153 : 1048 1054.
32. Gieler U, Ring J, Wahn U. Neurodermitisschulung. Dt Ärztebl 2001 98 : A3202 3209.
33. Diepgen TL, Fartasch M, Ring J, Scheewe S, Staab D, Szcepanski R, Werfel T, Wahn U, Gieler U. Neuro-dermitisschulung. Konzept und aktueller Stand der German Randomized Intervention Multizentre Study. Hautarzt 2003 54 : 946 951.
34. Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, Scheewe S, Scheidt R, Schmid-Ott G, Schnopp C, Szczepanski R, Werfel T, Wittenmeier M, Wahn U, Gieler U. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006 332 : 933 938.